NEOFAST

COMPOSITION: EACH ML CONTAINS NEOMYCIN SULFATE BP 0.5%W/V BECLOMETHASONE DIPROPIONATE BP 0.025%W/V CLOTRIMAZOLE BP 1%W/V LIDOCAINE HYDROCHLORIDE BP 2%W/V GLYCERINE AND PROPYLENE GLYCOL BASE QS

INDICATIONS: Local treatment of ear disorder